A Markov Process Analysis Comparing the Cost Effectiveness of Maintenance Therapy with Citalopram versus Standard Therapy in Major Depression
暂无分享,去创建一个
[1] Wayne Katon,et al. Adequacy and Duration of Antidepressant Treatment in Primary Care , 1992, Medical care.
[2] M. Weissman,et al. The epidemiology of depression. An update on sex differences in rates. , 1984, Journal of affective disorders.
[3] E. Souêtre,et al. Methodological approaches to pharmaco‐economics , 1994, Fundamental & clinical pharmacology.
[4] A. Amdisen,et al. Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders. , 1970, Lancet.
[5] S. Pauker,et al. The Markov Process in Medical Prognosis , 1983, Medical decision making : an international journal of the Society for Medical Decision Making.
[6] S. Montgomery,et al. A 24‐week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression , 1993, International clinical psychopharmacology.
[7] N. Damsbo,et al. Citalopram and imipramine in the treatment of depressive patients in general practice. A Nordic multicentre clinical study , 1994, International clinical psychopharmacology.
[8] J. Mitchell,et al. The hidden mental health network. Treatment of mental illness by nonpsychiatrist physicians. , 1985, Archives of general psychiatry.
[9] G. Dunbar,et al. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression , 1993, International clinical psychopharmacology.
[10] D. Blazer,et al. The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. , 1984, Archives of general psychiatry.
[11] Y. Davenport,et al. Follow-up of 53 Bipolar Manic-Depressive Patients , 1974, British Journal of Psychiatry.
[12] D. Kupfer,et al. Continuation drug therapy for major depressive episodes: how long should it be maintained? , 1986, The American journal of psychiatry.
[13] D. Revicki,et al. Cost Utility of Maintenance Treatment of Recurrent Depression with Sertraline Versus Episodic Treatment with Dothiepin , 1994, PharmacoEconomics.
[14] Peter Hertzman. The economic costs of mental illness in Sweden 1975 , 1983, Acta psychiatrica Scandinavica.
[15] Allan S. Detsky,et al. Guidelines for Economic Analysis of Pharmaceutical Products , 1993, PharmacoEconomics.
[16] H. Lehmann,et al. An 11‐year follow‐up study of 110 depressed patients , 1988, Acta psychiatrica Scandinavica.
[17] S Greenfield,et al. Detection of depressive disorder for patients receiving prepaid or fee-for-service care. Results from the Medical Outcomes Study. , 1989, JAMA.
[18] P. Bebbington,et al. What Price Depression? , 1994, British Journal of Psychiatry.
[19] J. Angst. Epidemiology of depression , 2005, Psychopharmacology.
[20] M. Schou,et al. Studies on the Course of Recurrent Endogenous Affective Disorders , 1970 .
[21] D. Kupfer,et al. Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression. Contributing factors. , 1991, Archives of general psychiatry.
[22] M. Weissman,et al. The course, morbidity, and costs of depression. , 1992, Archives of general psychiatry.
[23] D. Blazer,et al. The economic burden of depression. , 1986, General hospital psychiatry.
[24] S. Montgomery,et al. The Prophylactic Efficacy of Fluoxetine in Unipolar Depression , 1988, British Journal of Psychiatry.
[25] G. Brown,et al. Depression: Distress or Disease? Some Epidemiological Considerations , 1985, British Journal of Psychiatry.
[26] J. Mccombs,et al. The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population. , 1990, The Journal of clinical psychiatry.
[27] J. Rosenbaum,et al. Health economics of depression , 1993 .
[28] T. Mcguire. Measuring the economic costs of schizophrenia. , 1991, Schizophrenia bulletin.
[29] D. Rice,et al. Estimates of economic costs of alcohol and drug abuse and mental illness, 1985 and 1988. , 1991, Public health reports.
[30] M. Thase. Relapse and recurrence in unipolar major depression: short-term and long-term approaches. , 1990, The Journal of clinical psychiatry.
[31] C. Perris. THE COURSE OF DEPRESSIVE PSYCHOSES , 1968, Acta psychiatrica Scandinavica.
[32] M M Weissman,et al. Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. , 1984, Archives of general psychiatry.
[33] G. Andrews,et al. The economic costs of schizophrenia. Implications for public policy. , 1985, Archives of general psychiatry.
[34] D. Kupfer,et al. Five-year outcome for maintenance therapies in recurrent depression. , 1990, Archives of general psychiatry.
[35] M. Weinstein,et al. Clinical Decision Analysis , 1980 .
[36] L. George,et al. Depression, disability days, and days lost from work in a prospective epidemiologic survey. , 1990, JAMA.